12:00 AM
 | 
May 18, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

ACTOplus met XR pioglitazone/extended-release metformin regulatory update

FDA approved extended-release ACTOplus met XR to treat Type II diabetes in adults already receiving Actos pioglitazone and metformin or who have inadequate...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >